Author:
Goya Masahiko,Nagashima Michio,Hiroshima Ken-ichi,Hayashi Kentaro,Makihara Yu,Fukunaga Masato,An Yoshimori,Ohe Masatsugu,Sasaki Takeshi,Shiohira Shinya,Shirai Yasuhiro,Kawabata Mihoko,Ando Kenji,Isobe Mitsuaki,Hirao Kenzo
Subject
Cardiology and Cardiovascular Medicine
Reference22 articles.
1. US Food and Drug Administration. Medtronic Inc. Sprint Fidelis defibrillator leads class 1 recall. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152658.htm [accessed 22.09.15].
2. United States Food and Drug Administration. FDA safety communication. Available at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm284390.htm [accessed 22.09.15].
3. Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead;Maytin;J Am Coll Cardiol,2010
4. A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure;Da Costa;Arch Cardiovasc Dis,2012
5. Complications associated with revision of Sprint Fidelis leads. Report from the Canadian Heart Rhythm Society device advisory committee;Parkash;Circulation,2010
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献